COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Нерешительность в отношении вакцинации против COVID-19 во всем мире: краткий систематический обзор показателей принятия вакцинации
2021-02-16
SCID: 54.1/23vy7nu2
Discuss with AI
COVID-19 vaccine hesitancyhealthcare workerssystematic reviewvaccination ratesvaccine acceptance
Figures from the paper
Abstract (AI)
Utility of vaccine campaigns to control coronavirus 2019 disease (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and healthcare workers appears to have a decisive role in the successful control of the pandemic. The aim of this review was to provide an up-to-date assessment of COVID-19 vaccination acceptance rates worldwide. A systematic search of the peer-reviewed English survey literature indexed in PubMed was done on 25 December 2020. Results from 31 peer-reviewed published studies met the inclusion criteria and formed the basis for the final COVID-19 vaccine acceptance estimates. Survey studies on COVID-19 vaccine acceptance rates were found from 33 different countries. Among adults representing the general public, the highest COVID-19 vaccine acceptance rates were found in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%). However, the lowest COVID-19 vaccine acceptance rates were found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%). Only eight surveys among healthcare workers (doctors and nurses) were found, with vaccine acceptance rates ranging from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel. In the majority of survey studies among the general public stratified per country (29/47, 62%), the acceptance of COVID-19 vaccination showed a level of ≥70%. Low rates of COVID-19 vaccine acceptance were reported in the Middle East, Russia, Africa and several European countries. This could represent a major problem in the global efforts to control the current COVID-19 pandemic. More studies are recommended to address the scope of COVID-19 vaccine hesitancy. Such studies are particularly needed in the Middle East and North Africa, Sub-Saharan Africa, Eastern Europe, Central Asia, Middle and South America. Addressing the scope of COVID-19 vaccine hesitancy in various countries is recommended as an initial step for building trust in COVID-19 vaccination efforts.
Key Findings
1
Acceptance was lowest in Kuwait (23.6%), Jordan (28.4%), Italy (53.7%), Russia (54.9%), Poland (56.3%), the United States (56.9%), and France (58.9%).
2
Among healthcare workers, acceptance ranged from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel, based on only eight surveys.
3
Among the general public, acceptance was highest in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%), and China (91.3%).
4
In 29 of 47 country-stratified general-public surveys (62%), vaccine acceptance was at least 70%; low acceptance was particularly reported in the Middle East, Russia, Africa, and several European countries.
5
The review identifies vaccine hesitancy as a potential major obstacle to global pandemic control and calls for further research, especially in underrepresented regions.
6
The systematic review analyzed 31 peer-reviewed studies covering COVID-19 vaccine acceptance in 33 countries.
Research Object
COVID-19 vaccination acceptance among the general public and healthcare workers worldwide
Research Subject
Worldwide COVID-19 vaccine acceptance rates and cross-country variation, including vaccine hesitancy
Publication Details
Publication Date
2021-02-16
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest